Behçet's syndrome (BS) is a complex vasculitis, characterised by peculiar histological,
pathogenetic and clinical features. Superficial venous thrombosis (SVT) and deep vein …

Behçet's disease is a systemic vasculitis characterized by attacks of acute inflammation,
which can affect almost every vascularized area of the body. There is a close correlation …

Behçet's syndrome (BS) is a multisystemic vasculitis, characterized by different clinical
involvements, including mucocutaneous, ocular, vascular, neurological, and gastrointestinal …

Abstract Purpose of Review To assess current management of Behcet's disease (BD).
Controversies on therapeutic approaches to different manifestations, whether conventional …

Macular edema (ME) represents the most common cause for visual loss among uveitis
patients. The management of uveitic macular edema (UME) may be challenging, due to its …

Purpose We conducted a systematic review and meta-analysis to determine the
effectiveness and safety of anti-tumor necrosis factor-alpha (TNF-α) agents in the treatment …

To compare the efficacy of adalimumab (ADA) and infliximab (IFX) in patients with non-
infectious intermediate uveitis, posterior uveitis, and panuveitis. Demographic, clinical …

Non-infectious uveitis are intraocular inflammatory conditions caused by dysregulated
activation of the immune response without any detectable infectious agents. The aim of this …

Behcet's Disease was first described by a Turkish dermatologist, Hulusi Behcet, in 1937 as a
triple symptom complex; aphthous stomatitis, genital ulcers, and uveitis. Today, in light of …

Objective Since Behçet's syndrome (BS) is the prototype of inflammation‐induced
thrombosis, immunosuppressants are recommended in place of anticoagulants. We …